News Alert

HHS Secretary: 340B “Doesn’t Have the Transparency We Need”

United States Secretary of Health and Human Services Xavier Becerra speaks at Health Subcommittee hearing
The 340B program “doesn’t have the transparency we need,” HHS Secretary Becerra said during a House Energy & Commerce subcommittee hearing today.

U.S. Health and Human Services Secretary Xavier Becerra said today that the 340B program “doesn’t have the transparency we need” and “we are going to do what we can to make it more transparent.”

Becerra was asked about the drug

Read More »

News Alert

U.S. House Panel Debates 340B in Context of Health Care Transparency and Consolidation

Congresswoman Doris Matsui
“There’s been a lot of criticism of the 340B program lately and I’m concerned about the conversation on 340B happening today,” Rep. Doris Matsui (D-Calif.) said during a House Energy & Commerce health subcommittee hearing today.

The 340B program was discussed at length today during a U.S. House subcommittee hearing on price transparency and consolidation in health care, with three Republicans questioning whether hospitals are abusing the program and two Democrats and a Republican cautioning against

Read More »

RWC-340B Opposes and Hemophilia Alliance Questions PhRMA and NACHC’s Push to Remake 340B

RWC-340B Hemophilia Alliance wordmarks
RWC-340B rejected and Hemophilia Alliance criticized PhRMA and NACHC's joint plan to restructure the 340B program.

Ryan White Clinics for 340B Access has announced it opposes the drug industry’s joint plan with community health centers to restructure the 340B program, saying it will increase manufacturers’ “already astronomical profits at the expense of safety net providers.”

Hemophilia

Read More »

340B Expected to Be Addressed During U.S. House Hearing Today

E&C committee room
The 340B program is expected to come up today during a U.S. House Energy & Commerce health subcommittee hearing.

Lawmakers and heath care policy experts are expected to discuss the 340B program this afternoon during a U.S. House Energy & Commerce health subcommittee hearing.

The hearing on lowering health care costs through more price transparency and competition starts

Read More »

N.Y. State Health Centers Sue to Stop April 1 Shift of Medicaid Managed Care Drug Benefits to Fee for Service

Evergreen Health wordmark
Buffalo, N.Y.-based health center Evergreen Health and Harlem, N.Y.-based health health center Heritage Health and Housing asked a state court to halt Saturday's scheduled transfer of Medicaid drug benefits from managed care to fee for service.

The clock is ticking down in New York state to the scheduled April 1 transfer of Medicaid managed care drug benefits to Medicaid fee for service—a move that 340B safety net providers say would result in financial disaster.

Evergreen Health,

Read More »

Texas House Bill Addresses Medicaid MCO Bias Against 340B Pharmacies

Texas state capitol building with United States and Texas state flags
A bill in Texas would stop Medicaid MCOs and their PBMs from paying less than what Texas Medicaid pays for 340B-obtained drugs.

A bill has been introduced in Texas to stop Medicaid managed care organizations and their pharmacy benefit managers from reimbursing pharmacies for 340B-acquired drugs at less than what Texas Medicaid pays for the same 340B drugs.

Texas House Bill 1293

Read More »

PhRMA Discusses Joint 340B Reform Deal with Health Centers in Interview; Hospital Groups Denounce Plan

Nicole Longo headshot
“There is no way for 340B to be fixed without everybody coming to the table,” PhRMA spokesperson Nicole Longo said in an interview with 340B Report.

The fallout continues from drug makers and health centers’ decision to work together to change the 340B program, with the drug industry giving its first interview about the deal to 340B Report on Friday and several hospital groups jointly blasting

Read More »

Connecticut Governor’s First of Its Kind Three-Pronged 340B Bill Passes Hurdle in Legislature

Connecticut House of Representatives chamber
The Connecticut House might vote soon on a bill to require hospital reporting on 340B revenue, prohibit drug maker restrictions on 340B contract pharmacy use, and prohibit pharmacy benefit manager discrimination against 340B entities and pharmacies.

Connecticut Gov. Ned Lamont’s novel bill to require hospital reporting on 340B revenue, prohibit drug maker restrictions on 340B contract pharmacy use, and prohibit pharmacy benefit manager discrimination against 340B entities and pharmacies has passed its first test in the

Read More »

U.S. House Subcommittee Could Discuss 340B on Two Consecutive Days This Month

House Committee on E&C wall plaque
The House Energy & Commerce Health Subcommittee will review a draft drug shortages bill with 340B program implications.

U.S. House Republicans yesterday asked Department of Health and Human Services Secretary Xavier Becerra to testify March 29 about the Biden administration’s health care budget request.

Becerra will appear before the Energy & Commerce health subcommittee the day after it

Read More »

HRSA Wants Reporting Requirements on Use of 340B Savings and Compliance and Reporting Requirements on Use of Contract Pharmacies

HRSA building and signage
HRSA confirmed it will end a pandemic-era waiver program that allowed 340B drug use in certain offsite hospital locations.

The U.S. Health Resources and Services Administration has asked Congress for general rulemaking authority over the 340B program so it can establish “reporting requirements and definitions for the use of [340B] savings and contract pharmacy utilization.”

The Biden administration made

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live